Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2015-004866-27Phase 4
Phase 4, randomised, open-label trial of salmeterol + fluticasone in asthma (3 arms), sponsored by GSK. Primary endpoints: Serum cortisol weighted mean (0-12h) and Serum cortisol Cmin (0-12h).
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2015-004866-27.